Bharat Parenterals Limited (BOM:541096)

Market Cap	9.05B +24.8%
Revenue (ttm)	3.45B +1.5%
Net Income	-81.88M
EPS	-39.62
Shares Out	6.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	1.00 (0.07%)
Ex-Dividend Date	Sep 19, 2025

Volume	570
Open	1,282.05
Previous Close	1,335.15
Day's Range	1,282.05 - 1,374.30
52-Week Range	880.25 - 1,667.20
Beta	0.75
Analysts	n/a
Price Target	n/a
Earnings Date	May 18, 2026

About Bharat Parenterals

Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally. The company provides antibiotics, cardiovascular and central nervous system, antifungal, antimalarial, gastrointestinal tract/alimentary systems, analgesics, anaesthetics, quinolones, erectile dysfunction medicines, nutritional supplements, steroids and hormones, and other drugs. It also engages in manufacturing of general products in capsules, tablets, ointment and creams...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 393
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 541096

Financial Performance

In fiscal year 2026, Bharat Parenterals's revenue was 3.45 billion, an increase of 1.48% compared to the previous year's 3.40 billion. Losses were -81.88 million, -35.15% less than in 2025.